Evidence map›Paper›PMID 36140347›Full record

ArticleBiomedicines2022

Integrin β1/Cell Surface GRP78 Complex Regulates TGFβ1 and Its Profibrotic Effects in Response to High Glucose.

Jackie Trink, Renzhong Li, Evan Squire, Kian O'Neil, Phoebe Zheng, Bo Gao, Joan C Krepinsky

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Jackie TrinkDivision of Nephrology, McMaster University, St. Joseph's Healthcare, Hamilton, ON L8N 4A6, Canada.
Renzhong LiDivision of Nephrology, McMaster University, St. Joseph's Healthcare, Hamilton, ON L8N 4A6, Canada.
Evan SquireDivision of Nephrology, McMaster University, St. Joseph's Healthcare, Hamilton, ON L8N 4A6, Canada.
Kian O'NeilDivision of Nephrology, McMaster University, St. Joseph's Healthcare, Hamilton, ON L8N 4A6, Canada.
Phoebe ZhengDivision of Nephrology, McMaster University, St. Joseph's Healthcare, Hamilton, ON L8N 4A6, Canada.
Bo GaoDivision of Nephrology, McMaster University, St. Joseph's Healthcare, Hamilton, ON L8N 4A6, Canada.
Joan C KrepinskyDivision of Nephrology, McMaster University, St. Joseph's Healthcare, Hamilton, ON L8N 4A6, Canada.ORCID 0000-0002-6761-909X
St. Joseph’s Healthcare Hamilton · CA

Funding

CIHR PJT-148628
6 · The paper itself

Abstract

Diabetic kidney disease (DKD) is the leading cause of kidney failure worldwide. Characterized by overproduction and accumulation of extracellular matrix (ECM) proteins, glomerular sclerosis is its earliest manifestation. High glucose (HG) plays a central role by increasing matrix production by glomerular mesangial cells (MC). We previously showed that HG induces translocation of GRP78 from the endoplasmic reticulum to the cell surface (csGRP78), where it acts as a signaling molecule to promote intracellular profibrotic FAK/Akt activation. Here, we identify integrin β1 as a key transmembrane signaling partner for csGRP78. We show that it is required for csGRP78-regulated FAK/Akt activation in response to HG, as well as downstream production, secretion and activity of the well characterized profibrotic cytokine transforming growth factor β1 (TGFβ1). Intriguingly, integrin β1 also itself promotes csGRP78 translocation. Furthermore, integrin β1 effects on cytoskeletal organization are not required for its function in csGRP78 translocation and signaling. These data together support an important pathologic role for csGRP78/integrin β1 in mediating key profibrotic responses to HG in kidney cells. Inhibition of their interaction will be further evaluated as a therapeutic target to limit fibrosis progression in DKD.

Indexed as

cell signalingcell surface GRP78diabetic kidney diseasefibrosisintegrin β1mesangial cellTGFβ1

Identifiers

PMID36140347
PMCPMC9496450
OpenAlexW4295560290

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.